DIMENSIONAL FUND ADVISORS LP

Position in VERA — Vera Therapeutics, Inc.

CIK 354204 AUSTIN, TX

Position in VERA

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$22,650,170

+$11,435,455 QoQ

Shares Held

527,853

+89.4% QoQ

Ownership

0.732%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#32

of 217 holders

Holding Since

Dec 2022

12 quarters on record

Voting authority Sole 96% Shared 2% None 2%

Healthcare · as of Jun 30, 2026

DIMENSIONAL FUND ADVISORS LP holds $6,105,781,867 across 230 Biotechnology names. VERA ranks #55 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,168,956	$580,655,511
2	JAZZ	Jazz Pharmaceuticals plc	1,713,592	$412,924,262
3	REGN	Regeneron Pharmaceuticals, Inc.	559,687	$348,987,230
4	INCY	Incyte Corp	2,280,803	$258,551,825
5	EXEL	Exelixis, Inc.	4,426,620	$240,852,392
6	BMRN	Biomarin Pharmaceutical Inc	4,075,714	$233,212,353
7	ROIV	Roivant Sciences Ltd.	5,230,417	$185,104,455
8	KRYS	Krystal Biotech, Inc.	476,038	$176,929,041

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$22,650,170	527,853	+89.4%	Shares	Sole	2026-08-11
2026-03-31	$11,214,715	278,765	-20.8%	Shares	Sole	2026-05-07
2025-12-31	$17,819,506	351,886	-2.3%	Shares	Sole	2026-02-12
2025-09-30	$10,471,246	360,332	+134.5%	Shares	Sole	2025-11-12
2025-06-30	$3,620,700	153,680	+1016.2%	Shares	Sole	2025-08-12
2025-03-31	$330,707	13,768	-13.0%	Shares	Sole	2025-05-13
2024-12-31	$669,535	15,832	-10.7%	Shares	Sole	2025-02-13
2024-09-30	$783,754	17,732	0.0%	Shares	Sole	2024-11-07
2024-06-30	$641,543	17,732	0.0%	Shares	Sole	2024-08-09
2024-03-31	$764,603	17,732	-65.2%	Shares	Sole	2024-05-10
2023-12-31	$783,179	50,922	+342.9%	Shares	Sole	2024-02-07
2022-12-31	$222,486	11,498	—	Shares	Sole	2023-02-09
No filing history on record for this holder in this stock.